BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061GAK7. A total of 36 filers reported holding BIOMARIN PHARMACEUTICAL INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Wellesley Asset Management | 50,586 | $50,777,000 | 3.39% |
| MACKAY SHIELDS LLC | 76,920,000 | $76,828,000 | 1.86% |
| Sonora Investment Management Group, LLC | 8,300,000 | $8,336,000 | 0.79% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 37,527,000 | $37,482,000 | 0.66% |
| LOOMIS SAYLES & CO L P | 2,274,521 | $188,489,000 | 0.35% |
| Allianz Asset Management GmbH | 118,270,000 | $118,591,000 | 0.11% |
| PALISADE CAPITAL MANAGEMENT, LP | 3,143,000 | $3,141,000 | 0.08% |
| THRIVENT FINANCIAL FOR LUTHERANS | 14,900,000 | $14,807,000 | 0.04% |
| Jefferies Group LLC | 2,848,000 | $2,831,408 | 0.02% |
| FORESIGHT CAPITAL MANAGEMENT ADVISORS, INC. | 14,000 | $14,000 | 0.02% |